Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the completion of BioHive-2, Recursion’s new NVIDIA DGX SuperPOD AI supercomputer, powered by 63 DGX H100 systems with a total of 504 NVIDIA H100 Tensor Core GPUs interconnected by NVIDIA Quantum-2 InfiniBand networking. This NVIDIA-powered AI supercomputer results in four times faster speeds than Recursion’s original supercomputer, BioHive-1, in benchmark performance tests. Based on available data, BioHive-2 is the fastest supercomputer wholly owned and operated by any pharmaceutical company worldwide.
Related Posts
BioVie Announces Completion Of Last Patient Treatment Visit In Phase 3 Trial Of NE3107 In Mild To Moderate Alzheimer’s Disease
Expects to announce topline data expected in the November/December timeframe.Enrolled patients had underlying medical conditions that are known risk factors for dementia that NE3107 has the potential to improve.CARSON
Why Is Moderna Stock Trading Higher On Tuesday?
Moderna stock jumps post AACR 2024 presentation of mRNA-4157 + Keytruda data in advanced HPV-negative head and neck carcinoma. Positive responses in the Phase 1 trial, with a 27.3% objective response rate and 63.6% disease control rate. Promising results and ongoing trials.
Bank of America Analysts Increase Their Forecasts After Upbeat Earnings
Bank of America Corp (NYSE: BAC) reported better-than-expected earnings for its third quarter on Tuesday.